(2S,3R)-2-((S)-2-acetamido-2-cyclopentylacetamido)-3-hydroxy-N-(2-(((R)-2-hydroxy-1,2-oxaborolan-3-yl)amino)-2-oxoethyl)butanamide

ID: ALA5201848

PubChem CID: 168292113

Max Phase: Preclinical

Molecular Formula: C18H31BN4O7

Molecular Weight: 426.28

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CCOB1O)[C@@H](C)O)C1CCCC1

Standard InChI:  InChI=1S/C18H31BN4O7/c1-10(24)15(17(27)20-9-14(26)22-13-7-8-30-19(13)29)23-18(28)16(21-11(2)25)12-5-3-4-6-12/h10,12-13,15-16,24,29H,3-9H2,1-2H3,(H,20,27)(H,21,25)(H,22,26)(H,23,28)/t10-,13+,15+,16+/m1/s1

Standard InChI Key:  JDRUDVAWOPXUQK-AFCVYNCWSA-N

Molfile:  

 
     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
   -4.9550   -0.6574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2406   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5258   -0.6575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8110   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0963   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0963   -1.4827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3816   -0.2449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6669   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6669   -1.4827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3816   -1.8955    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0478   -1.8955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0478   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0478    0.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7625   -0.6575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4771   -0.2449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1920   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9067   -0.2449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6214   -0.6575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3362   -0.2449    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    2.1920   -1.4827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8110    0.5803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5258    0.9930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3403    1.8146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5388    1.8955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2065    1.1355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2406    0.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9550   -0.8163    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6243   -1.5510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -1.4584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3362    0.5803    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
  9 11  1  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 18 17  1  6
 18 19  1  0
 16 20  2  0
  4 21  1  1
 22 21  1  0
 22 23  1  0
 23 24  1  0
 25 24  1  0
 21 25  1  0
  2 26  2  0
 19 27  1  0
 27 28  1  0
 29 28  1  0
 18 29  1  0
 19 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5201848

    ---

Associated Targets(non-human)

SUB1 Subtilisin-like protease (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.28Molecular Weight (Monoisotopic): 426.2286AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Lidumniece E, Withers-Martinez C, Hackett F, Blackman MJ, Jirgensons A..  (2022)  Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.,  65  (19.0): [PMID:36137276] [10.1021/acs.jmedchem.2c01093]

Source